03
Jan
…The corporation Azimuth Biotech has outlined its plans to support the war effort against the Thargoids by improving ship anti-xeno firepower.
CEO Torben Rademaker was interviewed on The Tau Ceti Journal's official ICE-cast, where he explained:
"As you may recall, one of the many reasons Aegis became redundant was its poor record in improving AX armaments past the initial rush of designs. Azimuth Biotech has established a research and development division specifically designed to correct their failings at a steady, sustainable pace."
"One of the inherent limitations with Aegis's designs is the maximum number of AX weapons that a ship can be outfitted with. The enhanced versions based on Ryder and Nemo's designs share this limitation. We seek to increase the upper limit of AX weapons a ship can utilise, and our research teams are already reporting promising results."
One of the ICE-cast's